Sage Journals: Discover world-class research

Retricted access

Research article

First published 2023-3

Ophthalmic adverse effects of BRAF inhibitors

Clara M. Castillejo Becerra, Wendy M. Smith, Lauren A. Dalvin

European Journal of Ophthalmology

Free access

Review article

First published 2016-1

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Zeynep Eroglu, Antoni Ribas

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2025-10

BRAF inhibitors with or without MEK inhibitors in advanced BRAF-positive non-small cell lung cancer: A systematic review

Animesh Saha, T Raja, Amit Dutt Dwary [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2012-3

The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence

Charlotte Lemech, Jeffrey Infante, Hendrik-Tobias Arkenau

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2015-3

Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma

Sarah J. Welsh, Pippa G. Corrie

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2021

The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature

Amalia Anastasopoulou, Panagiotis T. Diamantopoulos, Chrysanthi Skalioti [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2023

Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literature

Panagiotis T Diamantopoulos, Amalia Anastasopoulou, Maria Dimopoulou [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2020-09

Acquired Secondary RAS Mutation in BRAF V600E -Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors

Maria E. Cabanillas, Ramona Dadu, Pryianka Iyer [...]

Thyroid®

Open access

Research article

First published 2022

Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors

Ting Xu, Xicheng Wang, Zhenghang Wang [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2015-01

BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF -Mutant Thyroid Cancer

Gerald S. Falchook, Michael Millward, David Hong [...]

Thyroid®

Search results